Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	88.26	46.47	24.68
Graham Fair Price	41.49	0.03	0.02
PEG	9041.78	0.78	< 0.005
Price/Book	-14997.58	-8.66	-0.06
Price/Cash Flow	-4248.39	-28.59	-0.66
Prices/Earnings	7448.79	64.84	0.86
Price/Sales	7448.79	0.99	0.01
Price/FCF	-4248.39	-28.59	-0.66
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-5.74	0.47	0.49
Operating Margin	84.28	< 0.005	< 0.005
ROA	100.00	< 0.005	< 0.005
ROE	-0.02	-0.03	-100.00
ROIC	-0.01	< 0.005	70.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.04	-0.06	-42.06
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.97	0.69	-29.57
EPS QOQ	1.01	0.83	-17.43
FCF QOQ	0.68	-2.47	265.45
Revenue QOQ	-0.60	1.00	67.09
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	166.57	78.87	-52.65
Days Sales Outstanding (DSO)	81.46	43.52	-46.58
Inventory Turnover	0.54	1.14	111.20
Debt/Capitalization	1.47	1.44	-1.64
Quick Ratio	0.46	0.49	5.73
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	-0.03	-0.03	-0.05
Cash	0.03	0.03	0.05
Capex	< 0.005	< 0.005	-128.69
Free Cash Flow	< 0.005	-0.01	-247.38
Revenue	0.14	0.29	100.10
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.93	0.93	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	24.10	10.37	-56.96
Naive Interpretation	Member

06 - Financial Health · Bad

Rating